Natural ceramide reverses Fas resistance of acid sphingomyelinase-/- hepatocytes

被引:97
作者
Paris, F
Grassmé, H
Cremesti, A
Zager, J
Fong, YM
Haimovitz-Friedman, A
Fuks, Z
Gulbin, E
Kolesnick, R
机构
[1] Mem Sloan Kettering Canc Ctr, Lab Signal Transduct, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA
[4] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA
关键词
D O I
10.1074/jbc.M008732200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The role of the second messenger ceramide in Fas-mediated death requires clarification. To address this issue, we generated hepatocytes from paired acid sphingomyelinase (ASMase; asmase)(+/+) and asmase(-/-) mice. asmase(-/-) hepatocytes, derived from 8-week old mice, manifested normal sphingomyelin content and normal morphological, biochemical, and biologic features. Nonetheless, ASMase-deficient hepatocytes did not display rapid ceramide elevation or apoptosis in response to Jo2 anti-Fas antibody. asmase(-/-) hepatocytes were not inherently resistant to apoptosis because staurosporine, which did not induce early ceramide elevation, stimulated a normal apoptotic response. The addition of low nanomolar quantities of natural C-16-ceramide, which by itself did not induce apoptosis, completely restored the apoptotic response to anti-Fas in asmase(-/-) hepatocytes. Other sphingolipids did not replace natural ceramide and restore Fas sensitivity. Overcoming resistance to Fas in asmase(-/-) hepatocytes by natural ceramide is evidence that it is the lack of ceramide and not ASMase which determines the apoptotic phenotype. The ability of natural ceramide to rescue the phenotype without reversing the genotype provides evidence that ceramide is obligate for Fas induction of apoptosis in hepatocytes.
引用
收藏
页码:8297 / 8305
页数:9
相关论文
共 87 条
  • [11] Lack of ceramide generation in TF-1 human myeloid leukemic cells resistant to ionizing radiation
    Bruno, AP
    Laurent, G
    Averbeck, D
    Demur, C
    Bonnet, J
    Bettaïeb, A
    Levade, T
    Jaffrézou, JP
    [J]. CELL DEATH AND DIFFERENTIATION, 1998, 5 (02) : 172 - 182
  • [12] Cross-talk between phosphatidylinositol 3-kinase and sphingomyelinase pathways as a mechanism for cell survival/death decisions
    Burow, ME
    Weldon, CB
    Collins-Burow, BM
    Ramsey, N
    McKee, A
    Klippel, A
    McLachlan, JA
    Clejan, S
    Beckman, BS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (13) : 9628 - 9635
  • [13] Alteration of the sphingomyelin/ceramide pathway is associated with resistance of human breast carcinoma MCF7 cells to tumor necrosis factor-alpha-mediated cytotoxicity
    Cai, ZZ
    Bettaieb, A
    ElMahdani, N
    Legres, LG
    Stancou, R
    Masliah, J
    Chouaib, S
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (11) : 6918 - 6926
  • [14] Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75
    CasacciaBonnefil, P
    Carter, BD
    Dobrowsky, RT
    Chao, MV
    [J]. NATURE, 1996, 383 (6602) : 716 - 719
  • [15] Chiu SM, 2000, INT J ONCOL, V16, P423
  • [16] Down-regulation of ceramide production abrogates ionizing radiation-induced cytochrome c release and apoptosis
    Chmura, SJ
    Nodzenski, E
    Kharbanda, S
    Pandey, P
    Quintas, J
    Kufe, DW
    Weichselbaum, RR
    [J]. MOLECULAR PHARMACOLOGY, 2000, 57 (04) : 792 - 796
  • [17] Chmura SJ, 1997, CANCER RES, V57, P4340
  • [18] Chmura SJ, 1997, CANCER RES, V57, P1270
  • [19] Dexamethasone-induced thymocyte apoptosis: Apoptotic signal involves the sequential activation of phosphoinositide-specific phospholipase C, acidic sphingomyelinase, and caspases
    Cifone, MG
    Migliorati, G
    Parroni, R
    Marchetti, C
    Millimaggi, D
    Santoni, A
    Riccardi, C
    [J]. BLOOD, 1999, 93 (07) : 2282 - 2296
  • [20] APOPTOTIC SIGNALING THROUGH CD95 (FAS/APO-1) ACTIVATES AN ACIDIC SPHINGOMYELINASE
    CIFONE, MG
    DEMARIA, R
    RONCAIOLI, P
    RIPPO, MR
    AZUMA, M
    LANIER, LL
    SANTONI, A
    TESTI, R
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) : 1547 - 1552